Literature DB >> 29775694

Advance Care Planning in a Multicultural Family Centric Community: A Qualitative Study of Health Care Professionals', Patients', and Caregivers' Perspectives.

Sumytra Menon1, Marijke C Kars2, Chetna Malhotra3, Alastair V Campbell4, Johannes J M van Delden2.   

Abstract

CONTEXT: Advance care planning (ACP) has been shown to improve end-of-life care, but it was developed in the U.S., and most research has been conducted in western communities.
OBJECTIVES: We aimed to study the attitudes and perceptions of patients with life-limiting illnesses, informal caregivers, doctors, nurses, and medical social workers regarding ACP in a multicultural family centric community.
METHODS: We conducted an explorative qualitative study, using focus groups and individual in-depth interviews. We used purposive sampling techniques to recruit 61 adults (15 doctors, 13 nurses, 5 medical social workers, 15 patients, and 13 caregivers) from multiple health care settings across the country.
RESULTS: The participants are genuinely anxious about the implementation of ACP. They had positive and negative expectations of ACP. Many were confused about the legal framework for health care decision-making and expected ACP to be of limited value because family members, rather than the patient, were usually the key decision makers.
CONCLUSION: A nuanced approach to ACP that considers the family network is required in multicultural family centric communities. Policies should be reconciled to create a more consistent message that respects patients, the family, and is legally coherent. Further research could focus on adaptations of ACP to promote its acceptance in such communities.
Copyright © 2018 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Advance care planning; advance directives; decision-making; terminal care

Mesh:

Year:  2018        PMID: 29775694     DOI: 10.1016/j.jpainsymman.2018.05.007

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  6 in total

Review 1.  Using Implementation Science to Further the Adoption and Implementation of Advance Care Planning in Rural Primary Care.

Authors:  Heather Nelson-Brantley; Carol Buller; Christie Befort; Edward Ellerbeck; Ariel Shifter; Shellie Ellis
Journal:  J Nurs Scholarsh       Date:  2019-09-23       Impact factor: 3.176

2.  Preferences on the Timing of Initiating Advance Care Planning and Withdrawing Life-Sustaining Treatment between Terminally-Ill Cancer Patients and Their Main Family Caregivers: A Prospective Study.

Authors:  Cheng-Pei Lin; Jen-Kuei Peng; Ping-Jen Chen; Hsien-Liang Huang; Su-Hsuan Hsu; Shao-Yi Cheng
Journal:  Int J Environ Res Public Health       Date:  2020-10-29       Impact factor: 3.390

3.  Regulating advance decision-making: potential and challenges for Malaysia.

Authors:  Hui Yun Chan
Journal:  Asian Bioeth Rev       Date:  2019-03-22

4.  Qualitative assessment of the intention of Chinese community health workers to implement advance care planning using theory of planned behavior.

Authors:  Bingyu Xing; Guanmian Liang; Jing Zhang; Jinsheng Zhang; Zhizhi Jiang; Qunfang Miao
Journal:  BMC Palliat Care       Date:  2021-12-10       Impact factor: 3.234

5.  Asian patients' perspectives on advance care planning: A mixed-method systematic review and conceptual framework.

Authors:  Diah Martina; Olaf P Geerse; Cheng-Pei Lin; Martina S Kristanti; Wichor M Bramer; Masanori Mori; Ida J Korfage; Agnes van der Heide; Judith Ac Rietjens; Carin Cd van der Rijt
Journal:  Palliat Med       Date:  2021-09-06       Impact factor: 4.762

6.  Longitudinal patterns and predictors of healthcare utilization among cancer patients on home-based palliative care in Singapore: a group-based multi-trajectory analysis.

Authors:  Qingyuan Zhuang; Poh-Heng Chong; Whee Sze Ong; Zhi Zheng Yeo; Cherylyn Qun Zhen Foo; Su Yan Yap; Guozhang Lee; Grace Meijuan Yang; Sungwon Yoon
Journal:  BMC Med       Date:  2022-09-22       Impact factor: 11.150

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.